Ikarian Capital, LLC G1 Therapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 12,248 shares of GTHX stock, worth $87,573. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,248Holding current value
$87,573% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GTHX
# of Institutions
7Shares Held
3.62MCall Options Held
11.7KPut Options Held
0-
Black Rock Inc. New York, NY3.08MShares$22 Million0.0% of portfolio
-
Tekla Capital Management LLC424KShares$3.03 Million0.04% of portfolio
-
Virtu Financial LLC New York, NY74.4KShares$531,6310.01% of portfolio
-
Bdo Wealth Advisors, LLC Jacksonville, FL35.2KShares$251,9230.01% of portfolio
-
Urban Wealth Management, LLC3.66KShares$26,1540.06% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $306M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...